Overview

Study With Palonosetron Alone in Preventing Chemotherapy-induced Nausea and Vomiting in Untreated Patients With Aggressive Non Hodgkin's Lymphomas Who Underwent Moderately Emetogenic Chemotherapy

Status:
Completed

Trial end date:
2008-07-01

Target enrollment:

Participant gender:

Summary

This is an open-label, multicenter phase II study in patients with aggressive Non Hodgkin Lymphoma scheduled to receive moderately emetogenic polychemotherapy (according to modified Hesketh classification for antiemetic therapy).

Phase:

Phase 2

Details

Lead Sponsor:

Gruppo Italiano Studio Linfomi

Treatments:

Emetics
Palonosetron